The topic of PFAS is inescapable and actively developing in the Commonwealth and across the country. Through this presentation MABA presenter(s) will provide a history and overview on the EPA PFAS Strategic Roadmap, the EPA Proposed Designation of Perfluorooctanoic Acid (PFOA) and Perfluorooctanesulfonic Acid (PFOS) as CERCLA Hazardous Substances, the Senate EPW Committee continued development of bipartisan PFAS legislation, as well as PFAS research including the National Collaborative PFAS Study conducted by Dr. Ian Pepper and his team at the University of Arizona. Attendees will leave the session informed and empowered to better assist their municipality's biosolids handling professionals with this difficult topic, as well as the citizens of their communities.

Learning Objectives:

• EPA Strategic Roadmap: 

  • Background on the following:

    • EPA Council on PFAS

    • Steps in the Strategic Roadmap, including risk assessment of PFOA and PFOS in biosolids

    • Difference between “risk assessment” and “risk management”

    • EPA recommendations prior to completion of the risk assessment

• EPA’s designation of PFOA and PFOS as CERCLA hazardous substances

• What is Superfund (CERCLA)? 

• EPA designation of PFOA and PFOS as CERCLA hazardous substances - background, updates

• Senate EPW Committee - potential passive receivers CERCLA exemption

• Legislation seeking to ban PFAS in consumer products

• National Collaborative PFAS Study

  • Objective of this research

  • States where samples have or will be collected

  • Type of research/results by year of study

  • Other studies taking place, including the WRF (Water Research Foundation) Unregulated Organic Chemicals in Biosolids: Prioritization, Fate and Risk Evaluation for Land Application - Project #5125 

• Research on PFAS & Biosolids

Join Mary to help you understand the complexities and ever-changing challenges of PFAS. 

Presenter
Mary Firestone Baker
Mid-Atlantic Biosolids Association
 

Cost
Member: $45
Non-Member: $75